The influence of indomethacin co-administration on ofloxacin levels in plasma and cerebrospinal fluid in rats

International Journal of Antimicrobial Agents

Volumn 23, Issue 4, 2004, Pages 371-376

  Dontas, Ismene ^a   Sokolis, Dimitrios P ^b   Giamarellos Bourboulis, Evangelos J ^a   Tzonou, Anastasia ^a   Giamarellou, Helen ^a,c   Karayannacos, Panayotis E ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^c NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Central nervous system adverse effects; Indomethacin; Ofloxacin; Pharmacokinetics

Indexed keywords

INDOMETACIN; OFLOXACIN;

ANIMAL EXPERIMENT; ARTICLE; BIOASSAY; BLOOD SAMPLING; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG SAFETY; FEMALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CENTRAL NERVOUS SYSTEM; DRUG THERAPY, COMBINATION; FEMALE; INDOMETHACIN; OFLOXACIN; RATS; RATS, WISTAR;

EID: 1842739119     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2003.09.016     Document Type: Article

References (20)

1. Janknegt R. Drug interactions with quinolones. J Antimicrob. Chemother. 26:1990;7-29.
2. Davies B.I., Maesen F.P.V. Drug interactions with quinolones. Rev. Infect. Dis. 11:1989;S1083-S1090.
3. Davey P.G. Overview of drug interactions with the quinolones. J. Antimicrob. Chemother. 22:1988;97-107.
4. Christ W. Central nervous system toxicity of quinolones: human and animal findings. J. Antimicrob. Chemother. 26:1990;219-225.
5. Ball P., Tillotson G. Tolerability of fluoroquinolone antibiotics. Past, present and future. Drug. Saf. 13:1995;343-358.
6. Christ W., Lehnert T., Ulbrich B. Specific toxicologic aspects of the quinolones. Rev. Infect. Dis. 10:1988;141-146.
7. Katagiri Y., Naora K., Ichikawa N., Hayashibara M., Iwamoto K. Absence of pharmacokinetic interaction between ofloxacin and fenbufen in rats. J. Pharm. Pharmacol. 41:1989;717-719.
8. Naora K., Katagiri Y., Ichikawa N., Hayashibara M., Iwamoto K. Enhanced entry of ciprofloxacin into the rat central nervous system induced by fenbufen. J. Pharmacol. Exp. Ther. 258:1991;1033-1037.
9. Naora K., Katagiri Y., Iwamoto K., Tanaka K., Yamaguchi T., Sekine Y. Effect of fenbufen on the pharmacokinetics of sparfloxacin in rats. J. Antimicrob. Chemother. 30:1992;673-683.
10. O'Donnell J.A., Gelone S.P. Fluoroquinolones. Infect. Dis. Clin. North Am. 14:2000;489-513.
11. Liles J.H., Flecknell P.A. The use of non-steroidal anti-inflammatory drugs for the relief of pain in laboratory rodents and rabbits. Lab. Anim. 26:1992;241-255.
12. Waynforth HB. Experimental and surgical technique in the rat. San Diego, CA: Academic Press; 1988.
13. Anhalt JP. Assays for antimicrobial agents in body fluids. In: Lennette EH, Balows A, Hausler Jr. WJ, Shadomy HJ (Eds.), Manual of clinical microbiology. 4th ed. Washington, DC.: American Society for Microbiology; 1985. p.1009-14.
14. Zar JH. Biostatistical analysis. 3rd ed. Englewood Cliffs, NJ: Prentice-Hall; 1996.
15. Rollof J., Vinge E. Neurologic adverse effects during concomitant treatment with ciprofloxacin, NSAIDs, and chloroquine: possible drug interaction. Ann. Pharmacother. 27:1993;1058-1059.
16. Brouwers J.R.B.J. Drug interactions with quinolone antibacterials. Drug Saf. 7:1992;268-281.
17. A responses by a new class of quinolones and non-steroidal anti-inflammatories in dissociated frog sensory neurones. Br. J. Pharmacol. 105:1992;13-18.
18. Kamei C., Sugimoto Y., Ohishi H., Okumuta Y., Kitazumi K. Epileptogenic activity induced by combined treatment with anti-inflammatory drugs and enoxacin and its inhibition by a calcium antagonist, nicardipine. Methods Find Exp. Clin. Pharmacol. 18:1996;579-588.
19. Brooks P.M., Day R.O. Nonsteroidal antiinflammatory drugs - differences and similarities. N. Engl. J. Med. 324:1991;1716-1724.
20. Delon A., Bouquet S., Huguet F., Brunet V., Courtois P., Couet W. Pharmacokinetic - pharmacodynamic contributions to the convulsant activity of fluoroquinolones in rats. Antimicrob. Agents Chemother. 43:1999;1511-1515.